Construction has been underway at the Scott Hamilton Proton Therapy Center, which will deliver state-of-the-art cancer treatment to patients in Middle Tennessee and beyond.
The two-story building includes three treatment rooms along with clinical and administrative office space. It is located on Carothers Parkway, which is a growing and developing healthcare hub in Franklin, Tennessee. The $99.6 million project is scheduled to treat the first patient in mid-2018. It is spearheaded by Provision Healthcare, a Knoxville-based developer of proton centers and comprehensive cancer centers with a focus on making proton therapy a clinical reality. The center will utilize Provision Healthcare’s ProNova SC360 proton system. The first ProNova SC360 system will treat the first patient at the Provision Center for Proton Therapy in Knoxville, Tennessee later this year.
Olympic figure skater and gold medalist, Scott Hamilton, is a resident of Franklin, a cancer survivor and patient advocate. He serves as a Provision board member and through his Scott Hamilton CARES Foundation funds cancer research and provides support and educational services for cancer patients and their families. “Since meeting Provision founder Terry Douglass, it has been my dream to bring proton therapy to my hometown and to cancer patients in Middle Tennessee and around the globe,” said Hamilton. “It’s thrilling to see construction as this vision becomes reality.”
“Our mission is to make proton therapy a clinical reality and to make this therapy more accessible to more patients around the world,” said Terry Douglass, Executive Chairman of Provision Healthcare. “We are blessed to be able to provide this cancer treatment to all patients who need it.”
With the addition of the Scott Hamilton Proton Therapy Center in Franklin, this will be the second proton therapy centered developed by the Provision team. The Provision Center for Proton Therapy in Knoxville, Tennessee opened in January 2014.
About Provision Healthcare, LLC
Provision Healthcare, LLC, (Provision) was formed in 2005 with the purpose of developing innovative healthcare solutions focused on improving patient care and clinical outcomes and developing support for research, educational, and charitable causes. Provision has developed a unique, comprehensive expertise in proton therapy that distinguishes it from other equipment suppliers and proton and cancer center developers and operators that have a much narrower focus. The combination of a unique expertise and innovative, entrepreneurial approach continues to propel Provision towards a position of industry leadership with respect to both cancer care and proton therapy.
About ProNova Solutions, LLC
A division of Provision Healthcare, ProNova is committed to making proton therapy accessible to a greater number of patients and physicians worldwide. ProNova was founded by former leaders of CTI Molecular Imaging, which brought positron emission tomography (PET) technology out of the laboratory and made it a clinical reality for millions of cancer patients. Today the same team is redefining cancer treatment once again with the introduction of the ProNova SC360 proton therapy system.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160925005025/en/Business Wire
Last updated on: 25/09/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.